Skip to main content
Market intelligence
IMDXSector not reported

Insight Molecular Diagnostics Inc. insider activity

In the last 90 days, 3 corporate insiders purchased $8,055,355 of stock on the open market.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$8,055,355
Corporate buyers
3
Latest transaction
Apr 27, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Apr 27, 2026Broadwood Partners L.p.Corporate insiderOpen Market Purchase570,184$3.56$2,032,250
Apr 27, 2026Broadwood Capital IncCorporate insiderOpen Market Purchase570,184$3.56$2,032,250
Apr 27, 2026Neal C BradsherCorporate insiderOpen Market Purchase570,184$3.56$2,032,250